A1 Adenosine Receptor Agonists: Medicinal Chemistry and Therapeutic Potential

Author(s): S. A. Hutchinson, P. J. Scammells

Journal Name: Current Pharmaceutical Design

Volume 10 , Issue 17 , 2004

Become EABM
Become Reviewer


Adenosine receptors are widely distributed in the body and modulate numerous physiological processes. Four receptor subtypes (termed A1, A2A, A2B and A3) have been identified based on their pharmacological profile and cloning. Activation of the A1 adenosine receptors produces a number of effects including a reduction in heart rate and atrial contractility, the attenuation of the stimulatory actions of catecholamines on the heart as well as a reduction of lipolysis in adipose tissue. As a result, A1AR agonists have been targeted as anti-arrhythmic and cardioprotective agents. This review discusses the synthesis, structure-activity relationships and therapeutic potential of A1AR agonists.

Keywords: Adenosine, anti-arrhythmic, A1AR agonists, cardioprotective agents

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2004
Page: [2021 - 2039]
Pages: 19
DOI: 10.2174/1381612043384204
Price: $65

Article Metrics

PDF: 9